Abstract
Vaccines are the most important strategy to fight many diseases. Plant-based vaccines have gained importance over the past decades, especially in combating SARS-CoV-2 and cancer. Some plant-based vaccines remain in trial phases, but many of them have been applied and have yielded positive results. The production of vaccines in plants follows several steps: isolating the gene of interest and producing the desired vaccine. These vaccines are cheap, can be produced in large quantities, and have exhibited great immune responses. The production and purification of these plant-based vaccines, however, present many challenges. This chapter overviews the current status of plant-based vaccines and their production.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adem, M., Beyene, D., & Feyissa, T. (2017). Recent achievements obtained by chloroplast transformation. Plant Methods, 13(1), 1–11.
Aghebati-Maleki, L., Bakhshinejad, B., Baradaran, B., Motallebnezhad, M., Aghebati-Maleki, A., Nickho, H., et al. (2016). Phage display as a promising approach for vaccine development. Journal of Biomedical Science, 23(1), 1–18.
Altindis, E., Iz, S. G., Ozen, M. O., Nartop, P., Gurhan, I. D., & Gurel, A. (2014). Plant derived edible vaccines and therapeutics. Frontiers in Clinical Drug Research - Anti Infectives, 1(200), 10.2174.
Athey-Pollard, A., Burns, C., Peter, R., Bailey, A., & Foster, G. D. (2002). PEG-mediated and Agrobacterium-mediated transformation in the mycopathogen Verticillium fungicola. Mycological Research, 106(1), 4–11.
Atiq, G., Nasrullah Khan, N., Raheem, M. A. R., & Iqbal, R. K. (2019). Plant transformation in biotechnology. Middle East Journal of Applied Science & Technology (MEJAST), 2(3), 103–123.
Bhatia, S., Bera, T., Dahiya, R., Bera, T., Bhatia, S., & Bera, T. (2015). Classical and nonclassical techniques for secondary metabolite production in plant cell culture. In Modern applications of plant biotechnology in pharmaceutical sciences (pp. 231–291).
Břiza, J., Vlasák, J., Ryba, Š., Ludvíková, V., & Niedermeierová, H. (2013). Transformation of tobacco cpDNA with fusion E7GGG/GUS gene and homologous recombination mediated elimination of the marker gene. Biotechnology & Biotechnological Equipment, 27(2), 3644–3648.
Burton, D. R. (2017). What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise. Cold Spring Harbor Perspectives in Biology, 9(11), a030262.
Cagliari, D., Dias, N. P., Galdeano, D. M., Dos Santos, E. Á., Smagghe, G., & Zotti, M. J. (2019). Management of pest insects and plant diseases by non-transformative RNAi. Frontiers in Plant Science, 10, 1319.
Capell, T., Twyman, R. M., Armario-Najera, V., Ma, J. K.-C., Schillberg, S., & Christou, P. (2020). Potential applications of plant biotechnology against SARS-CoV-2. Trends in Plant Science, 25(7), 635–643.
Carter, M., & Shieh, J. C. (2015). Guide to research techniques in neuroscience. Academic Press.
Chebolu, S., & Daniell, H. (2009). Chloroplast-derived vaccine antigens and biopharmaceuticals: Expression, folding, assembly and functionality. In Plant-produced microbial vaccines (pp. 33–54). Springer.
Chichester, J. A., Jones, R. M., Green, B. J., Stow, M., Miao, F., Moonsammy, G., et al. (2012). Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: A phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses, 4(11), 3227–3244.
Clark, M., & Maselko, M. (2020). Transgene biocontainment strategies for molecular farming. Frontiers in Plant Science, 11, 210.
Cui, Y., Qin, S., & Jiang, P. (2014). Chloroplast transformation of Platymonas (Tetraselmis) subcordiformis with the bar gene as selectable marker. PLoS One, 9(6), e98607.
Cummings, J. F., Guerrero, M. L., Moon, J. E., Waterman, P., Nielsen, R. K., Jefferson, S., et al. (2014). Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1) pdm09 virus: A phase 1 dose-escalation study in healthy adults. Vaccine, 32(19), 2251–2259.
D’Aoust, M. A., Couture, M. M. J., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. P. (2010). The production of hemagglutinin-based virus-like particles in plants: A rapid, efficient and safe response to pandemic influenza. Plant Biotechnology Journal, 8(5), 607–619.
Díaz, A., Villanueva, P., Oliva, V., Gil-Durán, C., Fierro, F., Chávez, R., & Vaca, I. (2019). Genetic transformation of the filamentous fungus Pseudogymnoascus verrucosus of Antarctic origin. Frontiers in Microbiology, 10, 2675.
Esland, S. (n.d.). Markers and reporter genes for engineering the chloroplast of Chlamydomonas reinhardtii. In Biology.
Gottschamel, J., Waheed, M. T., Clarke, J. L., & Lössl, A. G. (2013). A novel chloroplast transformation vector compatible with the gateway® recombination cloning technology. Transgenic Research, 22(6), 1273–1278.
Govea-Alonso, D. O., Cardineau, G. A., & Rosales-Mendoza, S. (2014). Principles of plant-based vaccines. In Genetically engineered plants as a source of vaccines against wide spread diseases (pp. 1–14). Springer.
Greer, A. L. (2015). Early vaccine availability represents an important public health advance for the control of pandemic influenza. BMC Research Notes, 8(1), 1–13.
Guillermo, M. J., Genelsa, E., Guiam-an, L., Ladaga, J., Maceren, I., Pangolima, Z. Z., & Abiso-Padilla, J. (n.d.). The promising potential of plant-based edible vaccines: A review. Journal homepage: www. ijrpr. com ISSN, 2582, 7421.
Hager, K. J., Pérez Marc, G., Gobeil, P., Diaz, R. S., Heizer, G., Llapur, C., et al. (2022). Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine. New England Journal of Medicine, 386, 2084.
Hiatt, A., Caffferkey, R., & Bowdish, K. (1989). Production of antibodies in transgenic plants. Nature, 342(6245), 76–78.
https://www.medicago.com (Medicago Inc., 2020).
Isakova-Sivak, I., Stepanova, E., Mezhenskaya, D., Matyushenko, V., Prokopenko, P., Sychev, I., et al. (2021). Influenza vaccine: Progress in a vaccine that elicits a broad immune response. Expert Review of Vaccines, 20(9), 1097–1112.
Jinturkar, K. A., Rathi, M. N., & Misra, A. (2011). Gene delivery using physical methods. In Challenges in delivery of therapeutic genomics and proteomics (pp. 83–126). Elsevier.
Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., et al. (1999). A plant-derived edible vaccine against hepatitis B virus. The FASEB Journal, 13(13), 1796–1799.
Kaushal, C., Abdin, M. Z., & Kumar, S. (2020). Chloroplast genome transformation of medicinal plant Artemisia annua. Plant Biotechnology Journal, 18(11), 2155.
Khan, A., Khan, A., Khan, I., Shehzad, M. A., Ali, W., Muhammad, A., & Akif, M. (2019). A review on natural way of vaccination: Plant derived edible vaccines. Journal of Vaccines and Immunology, 5(1), 018–021.
Khattak, S. H., Begum, S., Aqeel, M., Fayyaz, M., Bangash, S. A. K., Riaz, M. N., Saeed, S., Ahmed, A., & Ali, G. M. (2020). Investigating the allelic variation of loci controlling rust resistance genes in wheat (Triticum Aestivum L.) land races by SSR marker. Applied Ecology and Environmental Research, 18(6), 8091–8118.
Kim, M.-Y., Yang, M.-S., & Kim, T.-G. (2009). Expression of dengue virus E glycoprotein domain III in non-nicotine transgenic tobacco plants. Biotechnology and Bioprocess Engineering, 14(6), 725–730.
Kirk, D. D., McIntosh, K., Walmsley, A. M., & Peterson, R. K. (2005). Risk analysis for plant-made vaccines. Transgenic Research, 14(4), 449–462.
Korban, S. S. (2002). Targeting and expression of antigenic proteins in transgenic plants for production of edible oral vaccines. In Vitro Cellular & Developmental Biology-Plant, 38(3), 231–236.
Kumar, A. U., & Ling, A. P. K. (2021). Gene introduction approaches in chloroplast transformation and its applications. Journal of Genetic Engineering and Biotechnology, 19(1), 1–10.
Kumar, M., Kumari, N., Thakur, N., Bhatia, S. K., Saratale, G. D., Ghodake, G., et al. (2021). A comprehensive overview on the production of vaccines in plant-based expression systems and the scope of plant biotechnology to combat against SARS-CoV-2 virus pandemics. Plants, 10(6), 1213.
Lacroix, B., & Citovsky, V. (2020). Biolistic approach for transient gene expression studies in plants. In Biolistic DNA delivery in plants (pp. 125–139).
Laere, E., Ling, A. P. K., Wong, Y. P., Koh, R. Y., Mohd Lila, M. A., & Hussein, S. (2016). Plant-based vaccines: Production and challenges. Journal of Botany, 2016, 1.
Landry, N., Ward, B. J., Trépanier, S., Montomoli, E., Dargis, M., Lapini, G., & Vézina, L.-P. (2010). Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS One, 5(12), e15559.
Lavelle, E. C., & Ward, R. W. (2022). Mucosal vaccines—Fortifying the frontiers. Nature Reviews Immunology, 22(4), 236–250.
Li, J.-F., Park, E., von Arnim, A. G., & Nebenführ, A. (2009). The FAST technique: A simplified agrobacterium-based transformation method for transient gene expression analysis in seedlings of Arabidopsis and other plant species. Plant Methods, 5(1), 1–15.
Liu, Z., & Friesen, T. L. (2012). Polyethylene glycol (PEG)-mediated transformation in filamentous fungal pathogens. In Plant fungal pathogens (pp. 365–375). Springer.
Liu, Y.-C., & Vidali, L. (2011). Efficient polyethylene glycol (PEG) mediated transformation of the moss Physcomitrella patens. JoVE (Journal of Visualized Experiments), 50, e2560.
Liu, L., Zhao, Q., & Goh, M. (2021). Perishable material sourcing and final product pricing decisions for two-echelon supply chain under price-sensitive demand. Computers & Industrial Engineering, 156, 107260.
Loessl, A., & Waheed, M. (2011). Chloroplast-derived vaccines against human diseases: Achievements, challenges and scopes (vol 9, pg 527, 2011). Plant Biotechnology Journal, 9(7), 817–817.
Low, L.-Y., Yang, S.-K., Kok, D.-X. A., Ong-Abdullah, J., Tan, N.-P., & Lai, K.-S. (2018). Transgenic plants: Gene constructs, vector and transformation method. In New visions in plant science (pp. 41–61).
Masani, M. Y. A., Noll, G. A., Parveez, G. K. A., Sambanthamurthi, R., & Prüfer, D. (2014). Efficient transformation of oil palm protoplasts by PEG-mediated transfection and DNA microinjection. PLoS One, 9(5), e96831.
Mathur, J., & Koncz, C. (1998). PEG-mediated protoplast transformation with naked DNA. In Arabidopsis Protocols (pp. 267–276). Springer.
Matsumoto, T. K., & Gonsalves, D. (2012). Biolistic and other non-Agrobacterium technologies of plant transformation. In Plant biotechnology and agriculture (pp. 117–129). Elsevier.
Matsuoka, A. (2015). Genetic engineering of Agrobacterium tumefaciens to target chloroplasts and identification of a novel nuclear localization signal of VIRD2 protein. University of Lethbridge (Canada).
McDonald, K. A., & Holtz, R. B. (2020). From farm to finger prick—A perspective on how plants can help in the fight against COVID-19. Frontiers in Bioengineering and Biotechnology, 8, 782.
Meriç, S., Gümüş, T., & Ayan, A. (2021). Plant-based Vaccines: The Future of Preventive Healthcare?. Botany—Recent Advances and Applications.
Mestecky, J., Nguyen, H., Czerkinsky, C., & Kiyono, H. (2008). Oral immunization: an update. Current Opinion in Gastroenterology, 24(6), 713–719.
Meyers, B., Zaltsman, A., Lacroix, B., Kozlovsky, S. V., & Krichevsky, A. (2010). Nuclear and plastid genetic engineering of plants: comparison of opportunities and challenges. Biotechnology Advances, 28(6), 747–756.
Nanjareddy, K., Arthikala, M.-K., Blanco, L., Arellano, E. S., & Lara, M. (2016). Protoplast isolation, transient transformation of leaf mesophyll protoplasts and improved Agrobacterium-mediated leaf disc infiltration of Phaseolus vulgaris: Tools for rapid gene expression analysis. BMC Biotechnology, 16(1), 1–14.
Nkanga, C. I., Ortega-Rivera, O. A., Shin, M. D., Moreno-Gonzalez, M. A., & Steinmetz, N. F. (2022). Injectable slow-release hydrogel formulation of a plant virus-based COVID-19 vaccine candidate. Biomacromolecules, 23(4), 1812–1825.
Obermeyer, G., Gehwolf, R., Sebesta, W., Hamilton, N., Gadermaier, G., Ferreira, F., ... & Bentrup, F. W. (2004). Over-expression and production of plant allergens by molecular farming strategies. Methods, 32(3), 235–240.
Ogrina, A., Skrastina, D., Balke, I., Kalnciema, I., Jansons, J., Bachmann, M. F., & Zeltins, A. (2022). Comparison of bacterial expression systems based on potato virus Y-like particles for vaccine generation. Vaccine, 10(4), 485.
Paolino, K. M., Regules, J. A., Moon, J. E., Ruck, R. C., Bennett, J. W., Remich, S. A., et al. (2022). Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults. Vaccine, 40(12), 1864–1871.
Parvathy, S. T. (2020). Engineering plants as platforms for production of vaccines. American Journal of Plant Sciences, 11(5), 707–735.
Perea Arango, I., Loza Rubio, E., Rojas Anaya, E., Olivera Flores, T., Gonzalez de la Vara, L., & Gómez Lim, M. A. (2008). Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. Plant Cell Reports, 27(4), 677–685.
Pineda, E., Moreno, C., Escobar, F., & Halffter, G. (2005). Frog, bat, and dung beetle diversity in the cloud forest and coffee agroecosystems of Veracruz, Mexico. Conservation Biology, 19(2), 400–410.
Rahimian, N., Miraei, H. R., Amiri, A., Ebrahimi, M. S., Nahand, J. S., Tarrahimofrad, H., et al. (2021). Plant-based vaccines and cancer therapy: Where are we now and where are we going? Pharmacological Research, 169, 105655.
Ramesh, V. M., Bingham, S. E., & Webber, A. N. (2004). A simple method for chloroplast transformation in Chlamydomonas reinhardtii. In Photosynthesis research protocols (pp. 301–307). Springer.
Rehman, L., Su, X., Guo, H., Qi, X., & Cheng, H. (2016). Protoplast transformation as a potential platform for exploring gene function in Verticillium dahliae. BMC Biotechnology, 16(1), 1–9.
Rehman, M. A., Saleem, R., Hasan, S. W., Inam, S., Uddin, S. Z., Saeed, M., Noor, S., Riaz, M. N., Ali, G.M., & Khattak, S. H. (2020). Economic assessment of cereal-legume intercropping system, a way forward for improving productivity and sustaining soil health. Ijbpas, 9(5), 1078–1089.
Rigano, M. M., & Walmsley, A. M. (2005). Expression systems and developments in plant-made vaccines. Immunology and Cell Biology, 83(3), 271–277.
Rogalska, T., Day, J., AbouHaidar, M., & Hefferon, K. (2011). Current status of plants as vaccine production platforms. Journal of Clinical and Cellular Immunology, 4, 2.
Rosales-Mendoza, S. (2020). Will plant-made biopharmaceuticals play a role in the fight against COVID-19? Expert Opinion on Biological Therapy, 20(6), 545–548.
Rosales-Mendoza, S., Cervantes-Rincón, T., Romero-Maldonado, A., Monreal-Escalante, E., & Nieto-Gómez, R. (2021). Transgenic plants expressing a Clostridium difficile spore antigen as an approach to develop low-cost oral vaccines. Biotechnology Progress, 37(3), e3141.
Saxena, J., & Rawat, S. (2014). Edible vaccines. In Advances in biotechnology (pp. 207–226). Springer.
Sharma, A. K., & Sharma, M. K. (2009). Plants as bioreactors: Recent developments and emerging opportunities. Biotechnology Advances, 27(6), 811–832.
Sharma, M., & Sood, B. (2011). A banana or a syringe: Journey to edible vaccines. World Journal of Microbiology and Biotechnology, 27(3), 471–477.
Shim, B.-S., Hong, K.-J., Maharjan, P. M., & Choe, S. (2019). Plant factory: New resource for the productivity and diversity of human and veterinary vaccines. Clinical and Experimental Vaccine Research, 8(2), 136–139.
Streatfield, S. J. (2005). Regulatory issues for plant-made pharmaceuticals and vaccines. Expert Review of Vaccines, 4(4), 591–601.
Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M., & Arntzen, C. J. (2000). Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. The Journal of Infectious Diseases, 182(1), 302–305.
Takeyama, N., Kiyono, H., & Yuki, Y. (2015). Plant-based vaccines for animals and humans: Recent advances in technology and clinical trials. Therapeutic Advances in Vaccines, 3(5–6), 139–154.
Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., et al. (2005). Immunogenicity in humans of an edible vaccine for hepatitis B. Proceedings of the National Academy of Sciences, 102(9), 3378–3382.
Tusé, D., Nandi, S., McDonald, K. A., & Buyel, J. F. (2020). The emergency response capacity of plant-based biopharmaceutical manufacturing-what it is and what it could be. Frontiers in Plant Science, 11, 1573.
Vermij, P., & Waltz, E. (2006). USDA approves the first plant-based vaccine. Nature Biotechnology, 24(3), 234.
Webster, D. E., Thomas, M. C., Huang, Z., & Wesselingh, S. L. (2005). The development of a plant-based vaccine for measles. Vaccine, 23(15), 1859–1865.
Yu, J., & Langridge, W. (2003). Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Research, 12(2), 163–169.
Yu, Y., Yu, P.-C., Chang, W.-J., Yu, K., & Lin, C.-S. (2020). Plastid transformation: How does it work? Can it be applied to crops? What can it offer? International Journal of Molecular Sciences, 21(14), 4854.
Yuan, G., Xu, X., & Zhang, W. (2019). Biolistic transformation of Haematococcus pluvialis with constructs based on the flanking sequences of its endogenous alpha tubulin gene. Frontiers in Microbiology, 10, 468625.
Yusibov, V., Hooper, D., Spitsin, S., Fleysh, N., Kean, R., Mikheeva, T., et al. (2002). Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine, 20(25–26), 3155–3164.
Zhang, H., Huang, R. Y. C., Jalili, P. R., Irungu, J. W., Nicol, G. R., Ray, K. B., et al. (2010). Improved mass spectrometric characterization of protein glycosylation reveals unusual glycosylation of maize-derived bovine trypsin. Analytical Chemistry, 82(24), 10095–10101.
Zhao, J., Yang, Y., Yang, D., Cheng, Y., Jiao, M., Zhan, G., et al. (2016). Characterization and genetic analysis of rice mutant crr1 exhibiting compromised non-host resistance to Puccinia striiformis f. sp. tritici (Pst). Frontiers in Plant Science, 7, 1822.
Zienkiewicz, M., Krupnik, T., Drozak, A., & Kania, K. (2019). PEG-mediated, Stable, Nuclear and Chloroplast Transformation of Cyanidioschizon merolae. Bio-Protocol, 9, e3355.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Saleem, A., Saeed, M.A., Shah, N.A., Kaleem, I., Ahmed, H., Khattak, S.H. (2024). Using Plants as Vaccines. In: Hashmi, M.Z., Saeed, A., Musharraf, S.G., Shuhong, W. (eds) Recent Advances in Industrial Biochemistry. Springer, Cham. https://doi.org/10.1007/978-3-031-50989-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-50989-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-50988-9
Online ISBN: 978-3-031-50989-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)